Neuberger Berman Group LLC Verona Pharma PLC Transaction History
Neuberger Berman Group LLC
- $118 Billion
- Q2 2024
A detailed history of Neuberger Berman Group LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Neuberger Berman Group LLC holds 141,494 shares of VRNA stock, worth $3.82 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
141,494
Previous 214,231
33.95%
Holding current value
$3.82 Million
Previous $3.45 Million
40.63%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VRNA
# of Institutions
137Shares Held
66.7MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$206 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$151 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$108 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$95.9 Million7.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.31MShares$89.6 Million2.82% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $1.65B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...